Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 

Newsletter December 2015

Gene Therapy Net Banner
News: Cancer Gene Therapies: FDA Officials Highlight Regulatory Approaches
As gene therapies begin to get a foothold among other cancer treatments, the US Food and Drug Administration (FDA) is taking a more flexible, data-driven approach for the preclinical testing programs of these biologically complex products, according to a new review from five FDA officials in Cancer Gene Therapy.
Although FDA has yet to approve a gene therapy to treat cancer, the authors note that about two-thirds of gene therapy clinical trials are for cancer treatments. In order to help industry and academia with these trials, the agency has released a number of guidance documents, including recent recommendations for microbial vectors used for gene therapy and how shedding studies for virus and bacteria-based gene therapies and oncolytic products should be designed.

Read more...

Conference: Symposium and educational session of the Netherlands Society of Gene and Cell Therapy (NVGCT)
The 2016 NVGCT Spring Symposium will be held on March 10 and 11, 2016 in Lunteren, The Netherlands. The theme is gene delivery. Several stablished keynote speakers have already confirmed their presence. In addition several educational lectures will be presented. Register now before 31 January 2016.
Recent clinical successes have boosted the interest for Gene Therapy. The number of trials both for acquired and inherited diseases will increase significantly in the near future. Because of this and the changes in legislation the NVGCT has decided to also organize an educational session in collaboration with UniQure, the COGEM, Bureau GGO, ARM and the CCMO, on how to fill in the applications to help your with the obtaining the permits in an efficient way and to start performing your gene therapy trial in the Netherlands without delays.

Read more...

Conference: Adoptive T- Cell Therapy Congress
The Adoptive T- Cell Therapy Congress takes place at the Millennium Gloucester Hotel in London from March 15-16, 2016. We have already confirmed keynote speakers such as Renier Brentjens, Memorial Sloan Kettering Cancer Centre, USA; David Gilham, University of Manchester, UK; Inge Marie Svane, University of Copenhagen, Denmark amongst others to lead sessions at the event.
Over 80 scientists and researchers from biotech, big pharma, academia and the wider service community will be gathering to discuss progress and share insight on strategies – including Car-T, TILS and TCR – that are critical to furthering the development of viable T-cell therapies.
Key topic sessions will cover advancements in T-cell engineering, efficacy in different cancer models, results from human and clinical studies, and more.
If you are working in the field of T-cell therapy development and want to hear real case studies and practical insight, then join us at this exciting event.
Book the 2015 rate today: Academia, students and post-doctoral researchers receive a discounted rate to attend, plus Gene Therapy Net members receive an additional 15% off industry rates when they use code GTNET15 when booking online at www.tcellcongress.com/register/pricing.

Read more...

Company: Groupe Novasep
Novasep is a contract manufacturing organization specialized in the production of viruses & viral vectors for gene therapy. Novasep offers specific know-how for culture and purification using the latest single-use and reusable technologies. From process development to the fill & finish step, Novasep is committed to the success of its customers.
Read more...

- 25 - 27 January 2016, Phacilitate Cell & Gene Therapy World 2016, Washington DC, MD
- 3 - 4 March 2016, 18th International Conference on Cell and Gene Therapy - ICCGT 2016, Singapore
- 7 - 9 March 2016, International Society for BioProcess Technology 6th Spring Meeting - Viral vectors and vaccines, Washington, DC
- 9 - 11 March 2016, French Society of Cell and Gene Therapy (SFTCG) Annual Congress, Marseille, France
- 10 - 11 March 2016, Spring Symposium of the Netherlands Society of Gene & Cell Therapy (NVGCT), Lunteren, The Netherlands
- 15 April 2016, Annual conference of the British Society for Gene and Cell Therapy (BSGCT), London, UK
- 4 - 7 May 2016, American Society of Gene and Cell Therapy (ASGCT) 19th Annual Meeting, Washington, DC
- 19 – 21 May 2016, 5th International Conference and Exhibition on Cell & Gene Therapy, San Antonio, USA
- 25 - 28 May 2016, International Society for Cellular Therapy (ISCT) 22th Annual Meeting, Singapore
- 20 - 22 April 2016, World Orphan Drug Congress USA 2016, New York, NY
- 28 – 30 July 2016, The 22th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan
- 18 – 21 October 2016, XXIV Congress of the European Society of Gene and Cell Therapy (ESGCT) and the International Society for Stem Cell Research, Florence, Italy

Read more...

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net and Chikungunya Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?